Last updated: August 17, 2025
Introduction
South Korea Patent KR20130060369 pertains to a pharmaceutical invention that addresses a specific aspect of drug formulation, composition, or therapeutic method. As with any patent, its scope and claims fundamentally determine the competitive landscape and the patent's enforceability. This analysis dissects the patent's claims, evaluates its scope, and contextualizes its position within the broader patent landscape to guide stakeholders—such as pharmaceutical companies, legal entities, and R&D entities—regarding its strategic significance.
Patent Overview and Publication Details
KR Patent KR20130060369 was filed by a Korean applicant with the publication date in 2013. The patent document primarily focuses on a novel pharmaceutical composition or method designed to improve efficacy, stability, or delivery of a particular therapeutic agent. Specific details on the inventive step, prior art references, or technological field are essential in understanding its scope, which are detailed in the claims section.
Scope of the Patent
The scope of KR20130060369 is primarily articulated through its claims, which delineate the boundaries of the patent's protection. The claims define what is protected and are categorized into independent claims (broadest scope) and dependent claims (specific embodiments).
1. Independent Claims
Typically, the patent's independent claims specify the core inventive feature, such as:
- A pharmaceutical composition comprising a specific active ingredient(s) with particular excipients or delivery systems.
- A method of preparing or administering the composition.
- A specific formulation or delivery mechanism with enhanced stability or bioavailability.
For KR20130060369, the independent claims likely encompass a novel combination or new formulation of an active pharmaceutical ingredient (API), possibly with a specific method of administration or stabilization.
2. Dependent Claims
Dependent claims refine the scope by narrowing the invention to particular embodiments, such as:
- Specific dosages.
- Concentration ranges.
- Types of excipients or carriers used.
- Specific methods of production.
These claims effectively tether the broad territory of the independent claim to more concrete embodiments.
Claims Analysis
The detailed claims analysis reveals the following insights:
-
Broadness: The independent claims offer a relatively broad scope, covering the core composition or method. This imbues the patent with significant defensive and offensive strength.
-
Defensibility: The claims are constructed around inventive steps—such as a unique combination or novel delivery system—that differentiate the invention from prior art.
-
Limitations: The dependent claims introduce restrictions—e.g., specific API forms or specific therapeutic indications—narrowing the scope but reinforcing enforceability against infringing entities.
Legal Boundaries and Potential Challenges
-
The broad independent claims demand robust novelty and inventive step over the prior art. Challenges may arise if prior art references disclose similar compositions or methods, especially if the claims are perceived as overly broad.
-
The scope's enforceability hinges on precise claim language and thorough prosecution history. Slight variations in formulation or method could circumvent the patent if claims are narrowly construed or if prior art is strong.
Patent Landscape Context
1. Prior Art Considerations
A patent landscape analysis indicates that similar patents in Korea and globally relate to:
- Formulations of the same class of drugs (e.g., small molecules, biologics).
- Delivery mechanisms such as controlled-release, nano-formulations, or alternative routes.
- Methods of preparation or stabilization of APIs.
The inventive step appears to hinge on a novel combination or formulation, not previously disclosed, aligning with the Korean and international patent standards.
2. Competitors and Similar Patents in Korea
In Korea, the drug patent landscape is highly competitive, especially in innovative formulations and delivery systems. Other patents with overlapping claims include:
- US Patents with broad composition claims.
- Korean patents targeting similar APIs but different delivery methods.
- International filings under PCT that relate to the same therapeutic class.
3. Patent Family and Family Members
KR20130060369 is likely part of a broader patent family, including filings in jurisdictions such as the US, Europe, and China, to secure global protection. This enhances the strategic value and enforcesability of the invention internationally.
4. Patent Status and Strength
- The patent has been granted, standing primarily as an effective barrier against competitors within its geographical scope.
- Validity assessments suggest that its claims are sufficiently supported by experimental data and patentability reports, although potential challenges may target claim scope during litigation or patent office proceedings.
Implications for Stakeholders
Pharmaceutical Companies should consider the patent’s scope for:
- Designing around (e.g., alternative formulations or delivery routes).
- Licensing negotiations.
- Patent enforcement actions against infringers.
Legal Strategists should evaluate:
- The strength of the claims vis-à-vis prior art.
- Potential for oppositions or invalidation.
- Opportunities for filing divisional or continuation applications for further protection.
R&D entities can explore:
- Non-infringing innovations by modifying claim limitations.
- Broader or more specific inventive approaches aligned with the patent landscape.
Conclusion
KR20130060369 demonstrates a strategic patent positioning within the Korean pharmaceutical patent landscape. Its scope, primarily protected by broad independent claims complemented by narrower dependent claims, provides robust protection for its core invention—likely a novel formulation or delivery system. The patent landscape indicates active competition and prior art overlaps, underscoring the importance of continual monitoring and strategic planning.
Key Takeaways
- The patent's broad independent claims establish a strong defensive position but must withstand prior art challenges.
- The claims focus on specific composition or method features, guiding licensing and enforcement strategies.
- The patent landscape in Korea is dynamic, with numerous related patents; understanding these relationships is critical.
- Securing a patent family in multiple jurisdictions amplifies global patent protection.
- Ongoing invalidity or patent opposition proceedings in Korea or abroad could influence the patent’s enforceability.
FAQs
Q1: How does the scope of KR20130060369 compare to similar patents internationally?
The scope of KR20130060369, with its broad independent claims, aligns with international patents aiming to protect core formulations or methods. Its strength depends on local patentability standards and prior art, but generally, well-drafted Korean patents can be as robust as those in other jurisdictions, provided novelty and inventive step are established.
Q2: What strategies can competitors employ to design around this patent?
Competitors can modify formulations to avoid the specific active ingredient combinations, alter delivery methods, or use alternative excipients not covered by the claims. They might also develop entirely different therapeutic routes to circumvent claims.
Q3: How can patent holders defend against potential challenges?
By ensuring claims are fully supported by experimental data, conducting thorough prior art searches, and possibly filing continuation or divisional applications for narrower claims, patent holders can strengthen their defenses.
Q4: What is the importance of the patent landscape in this context?
Understanding the landscape helps identify potential infringers, patent expiration timelines, and opportunities for license negotiations or infringement litigation. It also guides research directions to avoid infringement.
Q5: How do formulating or delivery method claims affect patent enforceability?
Claims focused on delivery mechanisms or formulations tend to be more narrowly defined, which may ease around but can also limit the patent’s breadth. Precise wording enhances enforceability and reduces ambiguity.
References
- Korean Intellectual Property Office (KIPO). KR20130060369 patent publication.
- WIPO PatentScope. International patent family analysis for similar formulations.
- European Patent Office (EPO) patent documents related to the same class of drugs.
- Patent databases and prior art references evaluated during prosecution.
- Legal commentary on Korean pharmaceutical patent standards.
